MUNICH, Germany, July 30th, 2020 - 30 years ago a TOMTEC invention – 3D Ultrasound Technology – resulted in a quantum leap for diagnostic ultrasound. Today, the German company is set to once again revolutionize echocardiography through intelligent automation and web-based diagnostic workflows. Further to this, TOMTEC has joined the Philips’ family resulting in the creation of synergies set to impact diagnostic ultrasound in the most powerful way.

Measurement Automation: using Artificial Intelligence to improve diagnostic quality

TOMTEC has been at the cutting edge of automation in diagnostic ultrasound for many years. Automation is the key to reproducibility in the echo lab and TOMTEC has developed intelligent algorithms and AI-based data analytics that take user-variability out of the equation. TOMTEC-ARENA1 2020, which just has been released, is the result of these efforts.

With the addition of AI-based data analytics and automation, structures within the heart such as the Mitral Valve and endocardium can be detected, modeled and dynamically tracked in seconds; all with minimal interaction from the user. “The physician is no longer burdened with the time-consuming task of manual measurements such as left ventricular biplane volumes. This translates into valuable time savings and increased efficiencies. Harnessing the power of artificial intelligence, our software can independently perform many key echo measurements, from GLS to Ejection Fraction. This automation results in reproducible and user-independent results which means higher diagnostic confidence and quality,” says Gregor Malischnig, CMO at TOMTEC.


TOMTEC and PHILIPS: together we are better

Since joining the Philips’ family in 2017, both companies have gone from strength to strength. Many of the TOMTEC-ARENA1 applications are now available on Philips ultrasound systems including the EPIQ CVx. Philips customers can now benefit from a seamless workflow: starting with the ultrasound system and continuing, with flexibility, through to the reporting room. The strong partnership provides consistency through shared diagnostic tools, common workflows and user interface design. Most significantly, TOMTEC-ARENA maintains its vendor-agnostic advantage off-cart: TOMTEC software can analyze image data from all ultrasound manufacturers thus ensuring that each and every customer can benefit from the most recent innovations.


TOMTEC ZERO: the complete diagnostic web-based solution for Cardiology

TOMTEC ZERO2, the web-based version of the TOMTEC-ARENA1 software, offers increased efficiency and flexibility through mobile, web-based workflows. TOMTEC ZERO breaks down the barriers imposed by traditional workstations and the boundaries of hospitals by allowing any TOMTEC installation to be expanded for mobile, web-based use. TOMTEC ZERO provides access to diagnostic images, automated measurement packages and reporting via a web browser. In addition, TOMTEC ZERO now also provides dedicated stress echo review as well as access to prior studies.

TOMTEC ZERO provides complete diagnostic access no matter where the users are located within their clinical environment. “We developed our web technology to the point that TOMTEC ZERO is now ready for daily clinical use. In times of COVID-19, flexibility and adaptability to new workflows is more important than ever before. TOMTEC ZERO seamlessly complements the use of mobile ultrasound systems such as Philips LUMIFY and supports physicians who have to master new challenges such as mobile working, staff changes or social distancing,” says Matthijs Groot Wassink, TOMTEC CEO.


1 TOMTEC-ARENA is a trademark of TOMTEC Imaging Systems GmbH. Commercial availability in US pending
2 is part of TOMTEC-ARENA.